Upon completion of the educational activity, participants should be able to:

1. Managing Acute and Chronic Hypoparathyroidism

• Evaluate and implement evidence-based strategies for the diagnosis, treatment, and long-term management of acute and chronic hypoparathyroidism, including calcium and vitamin D therapy, emerging treatment options, and monitoring approaches to minimize complications and optimize patient outcomes.

2. Hypogonadism in Kallmann and Klinefelter Syndromes

• Differentiate the clinical presentations, diagnostic evaluations, and underlying mechanisms of hypogonadism in Kallmann and Klinefelter syndromes and develop individualized treatment strategies addressing hormone replacement, fertility considerations, and long-term health outcomes.

3. Understanding and Implementing the 2026 ACC/AHA/ADA Dyslipidemia Guideline

• Interpret and apply updated dyslipidemia guideline recommendations to assess cardiovascular risk, establish individualized lipid management goals, and select appropriate therapeutic interventions for patients with diabetes and other cardiometabolic risk factors.

4. Practical Tips for the Use of Advanced Diabetes Technologies

• Evaluate and integrate advanced diabetes technologies, including continuous glucose monitoring, automated insulin delivery systems, and emerging digital tools, to individualize diabetes management, improve glycemic outcomes, and address common barriers to clinical implementation.

5. Genetics of Pheochromocytoma/Paraganglioma and Adrenal Tumors: How to Counsel Your Patients

• Assess the role of genetic testing in pheochromocytoma, paraganglioma, and other adrenal tumors, and apply genetic findings to guide patient counseling, risk assessment, family screening, surveillance, and individualized management decisions.

6. From Biopsy to Follow-Up: Molecular Testing in Thyroid Cancer Management

• Evaluate the clinical utility of molecular testing throughout the thyroid cancer care continuum, including diagnostic assessment, risk stratification, treatment selection, and surveillance, to support personalized clinical decision-making.

7. Advances in Diabetes 2027: New Challenges in the Clinic

• Assess emerging evidence, therapeutic advances, and evolving challenges in diabetes care and incorporate appropriate diagnostic, pharmacologic, and technology-based strategies into individualized treatment plans to improve clinical outcomes.

8. The Right Fit: Finding the Right Obesity Treatment

• Compare current pharmacologic, behavioral, and procedural approaches to obesity management and develop individualized, evidence-based treatment strategies that consider patient characteristics, comorbidities, treatment effectiveness, safety, and long-term weight management.

9. Personalized Approach to Thyroid Nodules

• Apply individualized, risk-based approaches to the evaluation and management of thyroid nodules, incorporating clinical findings, ultrasound characteristics, cytology, and molecular testing to guide biopsy decisions, surveillance, and therapeutic interventions.

10. Beyond Insulin – Expanding the Toolbox for Type 1 Diabetes

• Evaluate emerging adjunctive therapies and non-insulin management strategies for type 1 diabetes, including their potential benefits, limitations, and safety considerations, to identify appropriate opportunities for improving glycemic control and overall patient outcomes.

11. From Diagnosis to Care Across the Lifespan: Practical Insights in Turner Syndrome and Premature Ovarian Insufficiency

• Differentiate the diagnostic and clinical considerations associated with Turner syndrome and premature ovarian insufficiency and implement individualized, multidisciplinary management strategies addressing hormone replacement, reproductive health, associated comorbidities, and long-term care across the lifespan.

12. Acromegaly: Current Perspectives in Diagnosis and Management

• Apply current diagnostic criteria, biochemical assessments, imaging approaches, and evolving treatment options to develop individualized management plans for patients with acromegaly, including strategies for monitoring disease control and addressing associated complications.

13. Beyond the Sequence – How Genome Structure Affects Hormone Action and Metabolic

• Explain how variations in genome structure influence hormone signaling, gene regulation, and metabolic function, and evaluate the potential implications of these mechanisms for understanding endocrine disorders and advancing personalized diagnostic and therapeutic approaches.

14. Beyond the Basics: Controversies and Advances in Gender-Affirming Hormone Therapy

• Critically evaluate emerging evidence, evolving clinical recommendations, and areas of controversy in gender-affirming hormone therapy to support individualized treatment decisions, appropriate monitoring, risk assessment, and patient-centered endocrine care.

15. Osteoporosis: Breaking News

• Evaluate recent advances in osteoporosis screening, fracture risk assessment, and therapeutic management, including emerging evidence on treatment selection, sequencing, and duration, to optimize fracture prevention and long-term skeletal health.

16. Hypercalcemia: Diagnosis and Management

• Apply a systematic approach to the differential diagnosis and evaluation of hypercalcemia, and select appropriate acute and longterm management strategies based on underlying etiology, disease severity, and individual patient risk factors.

17. The Newest Frontier for Metabolic Health – Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

• Assess current approaches to identifying, risk-stratifying, and managing metabolic dysfunction-associated steatotic liver disease (MASLD), including the role of metabolic risk factors, noninvasive diagnostic tools, lifestyle interventions, and emerging pharmacologic therapies in improving liver-related and cardiometabolic outcomes.

18. E. Chester Ridgway Lecture: From Data to Decisions in Thyroid Malignancy

• Integrate emerging clinical evidence, diagnostic findings, and risk-stratification tools into evidence-based decision-making for thyroid malignancy, with emphasis on individualized treatment selection, surveillance strategies, and balancing therapeutic benefits against potential risks.

19. The Endocrine Cause of Hypertension We Can't Afford to Miss

• Recognize clinical features suggestive of primary aldosteronism and apply appropriate screening, confirmatory evaluation, and treatment strategies to improve detection and management of this potentially treatable endocrine cause of hypertension.

20. A Systematic Approach to Hypoglycemia in Patients Without Diabetes

• Apply a structured diagnostic approach to hypoglycemia in patients without diabetes, including confirmation of clinically significant hypoglycemia, interpretation of biochemical findings, identification of underlying causes, and selection of appropriate management strategies.

21. Insights from the AHA Cardio-Kidney-Metabolic Syndrome Guidelines

• Interpret and apply current American Heart Association recommendations for cardiovascular-kidney-metabolic syndrome to identify patients at risk, assess disease progression, and implement integrated, evidence-based strategies for prevention and management of cardiovascular, renal, and metabolic complications.

22. Panel – Menopause in Focus: Balancing Competing Risks

• Evaluate the benefits, risks, and clinical considerations associated with menopausal hormone therapy and nonhormonal treatment options, and apply shared decision-making principles to develop individualized management strategies based on symptoms, comorbidities, and patient preferences.

23. Thyroid and Pregnancy in 2027: A Deep Dive

• Apply current evidence and clinical recommendations to the diagnosis and management of thyroid disorders before, during, and after pregnancy, including interpretation of thyroid function tests, treatment selection, and monitoring strategies to optimize maternal and fetal outcomes.

24. MACS the Knife: When to Watch and When to Operate – How to Approach Mild Cortisol Excess

• Evaluate the diagnostic criteria, clinical consequences, and management options for mild autonomous cortisol secretion (MACS), and apply individualized risk-benefit assessments to determine when surgical intervention or ongoing surveillance is most appropriate.

25. Pituitary Incidentalomas – A Practical Approach

• Implement a systematic approach to the evaluation and management of pituitary incidentalomas, incorporating hormonal assessment, imaging characteristics, visual function, and clinical risk factors to determine appropriate surveillance, specialist referral, and surgical intervention.

26. The Art and Science of Thyroid Hormone Management

• Apply evidence-based principles of thyroid hormone replacement and monitoring, including individualized dosing, interpretation of thyroid function tests, and management of persistent symptoms or special clinical circumstances, to optimize treatment effectiveness and patient outcomes.

Commercial Support 
There is no commercial support for this activity.